VEGF-A role in pancreatic cancer progression also influences tumor cells glucose metabolism: it enhances glycolysis via HIF-1α upregulation and NRP-1 co-receptor involvement. This evidence concerns the gene HIF1A and familial pancreatic carcinoma.